within Pharmacolibrary.Drugs.ATC.B;

model B01AA10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.00016666666666666666,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0025,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Diphenadione is a long-acting anticoagulant rodenticide of the indandione class. It was historically used for rodent control and acts by inhibiting the synthesis of vitamin K-dependent clotting factors. Diphenadione is not approved for human therapeutic use and is mostly of toxicological concern in cases of accidental or intentional poisoning.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters based on limited toxicological case reports and structural similarity to other indandione anticoagulants. No robust clinical PK study in humans.</p><h4>References</h4><ol><li>M D Freedman, A G Olatidoye,Clinically significant drug interactions with the oral anticoagulants.,Drug safety,1994<a href='https://pubmed.ncbi.nlm.nih.gov/8037888/'>https://pubmed.ncbi.nlm.nih.gov/8037888/</a></li><li>Irina Piatkov, Colin Rochester, Trudi Jones, Steven Boyages,Warfarin toxicity and individual variability-clinical case.,Toxins,2010<a href='https://pubmed.ncbi.nlm.nih.gov/22069565/'>https://pubmed.ncbi.nlm.nih.gov/22069565/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B01AA10;
